ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,068, issued on March 11, was assigned to President and Fellows of Harvard College.

"Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders" was invented by Gokhan S. Hotamisligil (Wellesley, Mass.), Mehmet F. Burak (Brighton, Mass.), Feyza Engin (Madison, Wis.), Scott B. Widenmaier (Brighton, Mass.), Karen Inouye (Boston), Elisabeth Helen Roberts (Slough, Great Britain), Adrian Richard Moore (Slough, Great Britain), Carl Brendan Doyle (Slough, Great Britain), Ralph Adams (Slough, Great Britain), Karine Jeannine Madeleine Herve (Vancouver, Canada), Shauna Mhairi Wales (Slough, Great Britain) and Kerry Louise Tyson (Slough, Great Britain).

According to the abs...